Core Insights - Kellanova delivered strong fourth-quarter 2024 results, with both top and bottom lines exceeding Zacks Consensus Estimates, and year-over-year earnings growth [1][4] - Despite a year-over-year decline in sales, organic sales increased due to improved volumes and price/mix [1][5] Financial Performance - Adjusted earnings per share (EPS) reached 92 cents, a 17.9% increase year over year, surpassing the Zacks Consensus Estimate of 82 cents [4] - Net sales totaled 3,093 million, but reflecting a 1.6% decline year over year due to unfavorable currency movements [5] - Organic net sales grew by 7%, driven by improved volumes and price/mix [5] - Adjusted operating profit increased by 14.4% to 470 million on a currency-neutral basis [6] Segment Performance - North America segment sales were 601 million, down 2% year over year, with organic sales dropping 1.2% [7] - Latin America revenues were 659 million, up 2.1% year over year, with organic sales jumping 36.4% [8] Cash Flow and Debt - Kellanova ended the quarter with cash and cash equivalents of 4,998 million, and total equity of 1,760 million for the year ended December 28, 2024, with capital expenditures of 1,132 million [9] Stock Performance - Kellanova's shares have increased by 10.5% over the past six months, outperforming the industry growth of 5.3% [10]
Kellanova Q4 Earnings Beat, Price/Mix & Volumes Drive Organic Sales